GAS surveillance. emm12 emm28 emm89 GAS GAS. A GAS Streptococcus pyogenes GAS GAS PSAGN GAS GAS. emm. Vol. 26 No GAS surveillance study group

Size: px
Start display at page:

Download "GAS surveillance. emm12 emm28 emm89 GAS GAS. A GAS Streptococcus pyogenes GAS GAS PSAGN GAS GAS. emm. Vol. 26 No GAS surveillance study group"

Transcription

1 014 Vol. 6No. 11 A 1 1 GAS surveillance study group A GAS GAS surveillance study group01 GAS 44 PCR 60 GAS emm emm8emm8 GAS emm GAS A GASStreptococcus pyogenes GAS GAS 1, GAS GAS GAS PSAGN GAS Key wordsa emm

2 014 1GAS surveillance study group JA GAS surveillance study groupgas GAS PCR 1 GAS surveillance study group GAS WHO B emm 4 Streptococcus dysgalactiae subsp. equisimilis SDSE SDSE H l Todd HewittTHbroth l emm 4 TH broth DNA,000 rpm 0l EXTRA- GEN DNA DNase DW 40l DNA

3 014 Vol. 6No. 1 1 A DNA realtime PCR GAS SDSE slo DNA emm emm CDC web penicillingpcgampicillinabpcamoxicillinapccefdinircdn cefpodoximecpdxcefditorencdtrclarithromycincaazithromycinaz 8 PCR 1 GAS 60 SDSE 4 6 GAS 1 PCR SDSE GAS O slo PCR GAS emm emm emm 18 emm 6.1.6emm8 16.emm8 1. GAS

4 4 014 A emm n6 G IC gml 0.01gml 0.01gml 0.016gml gml 0.016gml gml mefa1.1 ermb 6. mefa mefa ermb emm8 ermb GAS emm emm emm8 emm8 4 1 mgkg emm GAS 4..8 GAS 1 GAS 1 GAS

5 014 Vol. 6No. 1 emm mgkg mgkg p emm GAS emm GAS 40 mgkg mgkg emm PCR slo DNA GAS 1 GAS GAS GAS T 1

6 6 014 GAS emm type mgkg W041 W1 W0 W W086 W ND emm emm8 emm8 W0 W4 W W01 W44 W6 W18 W ND emm4 1 emm emm4 emm emm4 1 emm emm4 emm8 W emm W06 W01 W08 W emm8 emm emm8 emm8 W1 6 1 emm emm8 W emm4 GAS GAS SDSE 8 emm emm 4,6, T N GAS emm 10 GAS GAS GAS GAS GAS GAS GAS PCR GAS 8. GAS,, GAS.. emm4. 4 emm8 emm8 emm emm4 emm6 6 GAS

7 014 Vol. 6No. 1 emm8 80 GAS 11 B 1 1 GAS 14 Seppälä 1 GAS emm GAS emm8 01 IDSA V 0 mgkg mgkg mgkg GAS IDSA GAS PKPD GAS time above ICTA IC 0 TA 114 mgkg 18 1

8 GAS IC 0 kg mg mg mg mg gml AUC 01 IC 0 ghrml gml BRL000Cravuranic acidamoxicillin Jap J Antibiotics mgjap J Antibiotics mg GAS GAS GAS GAS GAS GAS A 1 LucaHarari B, et alclinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin icrobiol , 00 H0101 4Wajima T, et aldistribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease. J ed icrobiol 18188, 008 orozumi, et alsimultaneous detection of

9 014 Vol. 6No. 1 pathogens in clinical samples from patients with communityacquired pneumonia by realtime PCR with pathogenspecific molecular beacon probes. J Clin icrobiol , 006 6Centers for Disease Control and PreventionCDC S. pyogenes emm sequence databasehttp:www. cdc.govncidodbiotechstrepstrepblast.htm to determine the emm type. Ubukata K, et alin vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefa and ermb genes that mediate macrolide resistance. J Infect Chemother 16, 00 8Shimomura Y, et alcomplete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndromestss. BC genomics 11, 011 Wajima T, et alassociations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 001. Int J Antimicrob Agents 44444, 01 Plainvert C, et alinvasive group A streptococcal infections in adults, rance Clin icrobiol Infect 180, 01 11orozumi, et alantibiotic susceptibility in relation to genotype of Streptococcus pneumoniae, Haemophilus influenzae, and ycoplasma pneumoniae responsible for communityacquired pneumonia in children. J Infect Chemother 14440, 01 1orozumi, et alassociations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections. Epidemiol Infect 1818, 01 1Richter SS, et alacrolideresistant Streptococcus pyogenes in the United States, Clin Infect Dis 41608, 00 14Liu X, et alhigh macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China. Pediatr Pulmonol , 00 1Seppälä H, et althe effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in inland. innish study group for antimicrobial resistance. N Engl J ed , 1 16Shulman ST, et alclinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis01 update by the infectious diseases society of America. Clin Infectious Dis 118, A A

10 ulticenter analysis of pharyngotonsillitis caused by group A hemolytic streptococcitherapeutic effect of oral lactam antibiotics and features of the agents Takeshi TAJIA 1, Takeaki WAJIA, Satoshi KOYAA 1, Satoshi IWATA, Kimiko UBUKATA, GAS surveillance study group 1 Department of Pediatrics, Hakujikai emorial Hospital Department of icrobiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences Department of Infectious Diseases, Keio University School of edicine In order to clarify the therapeutic effects of oral lactam antibiotics for pharyngotonsillitis caused by group A hemolytic streptococcigasand the epidemiological features of the agents, thegas surveillance study groupwas organized by the active participation of pediatricians at the clinic of this study. Pharyngeal swab samples before and after administration of the therapeutic agent were collected from 44 patients with pharyngotonsillitis between April and October, 01. GAS strains were isolated from a total of 608.of them by combining culture and PCR. olecular emm typing showed that the most frequent type was 6.1, followed by.6, emm816., and emm81.. GAS isolates, as the causative agent, have had significant changes epidemiologically in recent years. No strains with lactam resistance have been identified in contrast to macrolideresistant strains at a high percentage among prevalent emm type strains. Amoxicillin, cefdinir, and cefditoren of the representative oral lactams have been used for all cases as the therapeutic agent. There were no significant differences in clinical efficacy by type of antibiotics and dosing conditionstwice or three times daily. However, the effectiveness of oral cephalosporins was slightly lower with administration twice daily than with administration three times a day. Based on the above findings, surveillance based on molecular epidemiology and antimicrobial susceptibility of GAS is necessary for selecting the best therapeutical agent, in addition to giving further consideration to the dosing conditions during the treatment of pharyngotonsillitis

Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease

Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease Journal of Medical Microbiology (2008), 57, 1383 1388 DOI 10.1099/jmm.0.2008/002642-0 Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease

More information

Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR (1167)

Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR (1167) From the Japanese Association of Medical Sciences The Japanese Association for Infectious Diseases Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR

More information

Group B streptococcal infection;. Bacteremia without a focus occurs in 80-85%,. July has been recognised as Group B Strep Awareness Month,.

Group B streptococcal infection;. Bacteremia without a focus occurs in 80-85%,. July has been recognised as Group B Strep Awareness Month,. Group B streptococcal infection;. Bacteremia without a focus occurs in 80-85%,. July has been recognised as Group B Strep Awareness Month,. 12-10-2017 Group B streptococci are uniformly sensitive to penicillin

More information

Control Sciences & Kitasato Institute for Life Sciences, Kitasato University Shirokane, Minato-ku, Tokyo , Japan

Control Sciences & Kitasato Institute for Life Sciences, Kitasato University Shirokane, Minato-ku, Tokyo , Japan AAC Accepts, published online ahead of print on 30 March 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.01716-08 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

Macrolides & Ketolides. Objectives. Protein Synthesis

Macrolides & Ketolides. Objectives. Protein Synthesis Macrolides & Ketolides Elizabeth D. Hermsen, Pharm.D. Infectious Diseases Research Fellow University of Minnesota College of Pharmacy bjectives Participant should be able to explain macrolide/ketolide

More information

- Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including

- Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including KHOA DICH VU HO HAP - Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including wheezing, coryza, bronchopneumonia. -

More information

DISTRIBUTION OF MACROLIDE-RESISTANT GENES AMONG ISOLATES OF MACROLIDE- RESISTANT STREPTOCOCCUS PYOGENES AND STREPTOCOCCUS PNEUMONIAE IN SERBIA

DISTRIBUTION OF MACROLIDE-RESISTANT GENES AMONG ISOLATES OF MACROLIDE- RESISTANT STREPTOCOCCUS PYOGENES AND STREPTOCOCCUS PNEUMONIAE IN SERBIA Arch. Biol. Sci., Belgrade, 66 (1), 93-98, 2014 DOI:10.2298/ABS1401093G DISTRIBUTION OF MACROLIDE-RESISTANT GENES AMONG ISOLATES OF MACROLIDE- RESISTANT STREPTOCOCCUS PYOGENES AND STREPTOCOCCUS PNEUMONIAE

More information

Original Article Clinical Microbiology INTRODUCTION

Original Article Clinical Microbiology INTRODUCTION Original Article Clinical Microbiology Ann Lab Med 2018;38:212-219 https://doi.org/10.3343/alm.2018.38.3.212 ISSN 2234-3806 eissn 2234-3814 Molecular Epidemiological Features and Antibiotic Susceptibility

More information

Key words: group A, /3-hemolytic streptococci, serotype, pyrogenic exotoxin, antibiotic resistance

Key words: group A, /3-hemolytic streptococci, serotype, pyrogenic exotoxin, antibiotic resistance Key words: group A, /3-hemolytic streptococci, serotype, pyrogenic exotoxin, antibiotic resistance Table 1 Age of patients and group A streptococcal infections Table 2 Relationship between M-and T-type

More information

OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae

OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae I. Importance of prenatal screening strategies II. Past approaches Erik Munson Clinical Microbiology Wheaton Franciscan Laboratory

More information

Laboratory Detection and Reporting of Streptococcus agalactiae

Laboratory Detection and Reporting of Streptococcus agalactiae Laboratory Detection and Reporting of Streptococcus agalactiae Erik Munson Clinical Microbiology Wheaton Franciscan Laboratory Milwaukee, Wisconsin The presenter states no conflict of interest and has

More information

telithromycin oral streptococci 140 telithromycin TEL azithromycin AZM clarithromycin CAM roxithromycin RXM levofloxacin LVFX ampicillin ABPC

telithromycin oral streptococci 140 telithromycin TEL azithromycin AZM clarithromycin CAM roxithromycin RXM levofloxacin LVFX ampicillin ABPC telithromycin 3 0 3 0 oral streptococci 0 telithromycintelazithromycin AZMclarithromycinCAMroxithromycinRXMlevofloxacinLVFXampicillinABPC erythromycinem TEL EM erm mef 5 Streptococcus mitis MIC90 ml TEL

More information

Upper Respiratory Infections. Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University

Upper Respiratory Infections. Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University Upper Respiratory Infections Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University Disclosures None Objectives Know the common age- and season-specific causes of pharyngitis

More information

Streptococcus pneumoniae 356 moxifloxacin (MFLX), garenoxacin (GRNX) sitafloxacin

Streptococcus pneumoniae 356 moxifloxacin (MFLX), garenoxacin (GRNX) sitafloxacin 2009 21 1) 1, 2) 1, 2) 1) 1) 2) 1) 1) 1) 1) 1) 1, 2) 1) 2) 20 2 29 21 1 14 Streptococcus pneumoniae 356 moxifloxacin (MFLX), garenoxacin (GRNX) sitafloxacin (STFX), DX619 S. pneumoniae S. pneumoniae 60

More information

Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(b) and mef(a) in South Korea

Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(b) and mef(a) in South Korea JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2003, p. 5787 5791 Vol. 41, No. 12 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.12.5787 5791.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.

More information

Application of real-time PCR for the detection of macrolide resistance in Belgian M. pneumoniae strains

Application of real-time PCR for the detection of macrolide resistance in Belgian M. pneumoniae strains Application of real-time PCR for the detection of macrolide resistance in Belgian M. pneumoniae strains K. Loens, S. C. Masha,, K. Lagrou, H. Goossens and M. Ieven Introduction (1) One of the smallest

More information

Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients

Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients Original Article Clinical Microbiology Ann Lab Med 2015;35:410-415 http://dx.doi.org/10.3343/alm.2015.35.4.410 ISSN 2234-3806 eissn 2234-3814 Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae

More information

Objectives. Pneumonia. Pneumonia. Epidemiology. Prevalence 1/7/2012. Community-Acquired Pneumonia in infants and children

Objectives. Pneumonia. Pneumonia. Epidemiology. Prevalence 1/7/2012. Community-Acquired Pneumonia in infants and children Objectives Community-Acquired in infants and children Review of Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America - 2011 Sabah Charania,

More information

Appropriate Use of Antibiotics for the Treatment of Acute Upper Respiratory Tract Infections in Adults

Appropriate Use of Antibiotics for the Treatment of Acute Upper Respiratory Tract Infections in Adults Appropriate Use of Antibiotics for the Treatment of Acute Upper Respiratory Tract Infections in Adults Kyong Ran Peck, M.D. Division of Infectious Diseases Sungkyunkwan University School of Medicine, Samsung

More information

Invasive Bacterial Diseases in the Arctic. Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 Copenhagen

Invasive Bacterial Diseases in the Arctic. Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 Copenhagen Invasive Bacterial Diseases in the Arctic Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 Copenhagen Outline Introduction to Alaska International Circumpolar Surveillance Invasive bacterial

More information

Genotyping of erythromycin resistant group C & G streptococci isolated in Chennai, south India

Genotyping of erythromycin resistant group C & G streptococci isolated in Chennai, south India Indian J Med Res 137, January 2013, pp 164-168 Genotyping of erythromycin resistant group C & G streptococci isolated in Chennai, south India D. Prabu & Thangam Menon Department of Microbiology, Dr A.L.

More information

STREPTOCOCCUS ANGINOSUS

STREPTOCOCCUS ANGINOSUS STREPTOCOCCUS ANGINOSUS Streptococcus anginosus Group Bacteria: No longer a Case of Mistaken Identity Ralph K. Funckerstorff et al. Article Review by Andrea Prinzi INTRODUCTION In 1906, two scientists

More information

Invasive Group A Streptococcal Disease (igas) in British Columbia 2017 Annual Summary

Invasive Group A Streptococcal Disease (igas) in British Columbia 2017 Annual Summary Invasive Group A Streptococcal Disease (igas) in British Columbia 2017 Annual Summary Background In 2016, BC experienced a higher incidence of igas than observed in 2009 through 2015, with a rate surpassing

More information

Antibiotic resistance pattern of streptococcus pyogenes isolated from clinical samples with special reference to quinolone resistance

Antibiotic resistance pattern of streptococcus pyogenes isolated from clinical samples with special reference to quinolone resistance Original Research Article DOI: 10.18231/2394-5478.2017.0022 Antibiotic resistance pattern of streptococcus pyogenes isolated from clinical samples with special reference to quinolone resistance Thipperudraswamy.

More information

PHENOTYPES AND GENOTYPES OF MACROLIDE-RESISTANT STREPTOCOCCUS PNEUMONIAE IN SERBIA

PHENOTYPES AND GENOTYPES OF MACROLIDE-RESISTANT STREPTOCOCCUS PNEUMONIAE IN SERBIA Arch. Biol. Sci., Belgrade, 66 (1), 99-105, 2014 DOI:10.2298/ABS1401099H PHENOTYPES AND GENOTYPES OF MACROLIDE-RESISTANT STREPTOCOCCUS PNEUMONIAE IN SERBIA MIRJANA HADNAĐEV 1, INA GAJIĆ 2, VERA MIJAC 2,

More information

Jimmy's Got Cooties! Common Childhood Infections and How Best to Treat Them

Jimmy's Got Cooties! Common Childhood Infections and How Best to Treat Them Jimmy's Got Cooties! Common Childhood Infections and How Best to Treat Them Objectives:! Recognize and manage several infections commonly seen in Pediatric practice! Discuss best practices and current

More information

Streptococcal Pharyngitis

Streptococcal Pharyngitis Streptococcal Pharyngitis Guideline developed by JC Beavers, MD, in collaboration with the ANGELS Team. Last reviewed by JC Beavers, MD on November 2, 2016. Preface Streptococcal pharyngitis (ie, strep

More information

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin

More information

Abstract. Introduction

Abstract. Introduction ORIGINAL ARTICLE 10.1111/j.1469-0691.2009.02718.x Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A b-haemolytic streptococcal pharyngitis/ tonsillitis

More information

Antibiotic Resistance of Non- pneumococcal Streptococci and Its Clinical Impact

Antibiotic Resistance of Non- pneumococcal Streptococci and Its Clinical Impact Antibiotic Resistance of Non- pneumococcal Streptococci and Its Clinical Impact 50 Nainee Desai, Judith Steenbergen, and David E. Katz 1 Introduction The taxonomy of streptococci has undergone major changes

More information

Multi-drug Resistant Serotype 19A Pneumococci in Toronto

Multi-drug Resistant Serotype 19A Pneumococci in Toronto TML Lab Rounds January 17, 2008 Multi-drug Resistant Serotype 19A Pneumococci in Toronto The Role of the Microbiology Lab Susan M. Poutanen, MD, MPH, FRCPC Microbiologist/ID Consultant, TML/MSH Assistant

More information

by author ESCMID Online Lecture Library Steroids in acute bacterial meningitis

by author ESCMID Online Lecture Library Steroids in acute bacterial meningitis Steroids in acute bacterial meningitis Javier Garau, MD, PhD University of Barcelona Spain ESCMID Summer School, Porto, July 2009 Dexamethasone treatment in childhood bacterial meningitis in Malawi: a

More information

Of 142 cases where sex was known, 56 percent were male; of 127cases where race was known, 90 percent were white, 4 percent were

Of 142 cases where sex was known, 56 percent were male; of 127cases where race was known, 90 percent were white, 4 percent were Group B Streptococcus Surveillance Report 2014 Oregon Active Bacterial Core Surveillance (ABCs) Center for Public Health Practice Updated: November 2015 Background The Active Bacterial Core surveillance

More information

Incidence per 100,000

Incidence per 100,000 Streptococcus pneumoniae Surveillance Report 2005 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services Updated: March 2007 Background

More information

27/11/2012. Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila pneumoniae Mycoplasma pneumonite

27/11/2012. Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila pneumoniae Mycoplasma pneumonite 8 «Evidence-based Medicine-» 27/11/2012,,,, : :,,,,,,,, (30%-50%) () (5%-10%) (40%-50%) 20% Infuenza A B Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila

More information

ORIGINAL ARTICLE /j x

ORIGINAL ARTICLE /j x ORIGINAL ARTICLE 10.1111/j.1469-0691.2007.01914.x Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients

More information

Identification of streptococcus dysgalactiae subsp. equisimilis from septic knee by 16S rrna gene sequencing

Identification of streptococcus dysgalactiae subsp. equisimilis from septic knee by 16S rrna gene sequencing http://dx.doi.org/10.7180/kmj.2016.31.1.79 KMJ Case Report Identification of streptococcus dysgalactiae subsp. equisimilis from septic knee by 16S rrna gene sequencing Ji Sang Park 1, Hye Won Kim 1, Jeong

More information

Adult invasive and non invasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France ( )

Adult invasive and non invasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France ( ) JCM Accepts, published online ahead of print on 22 May 2013 J. Clin. Microbiol. doi:10.1128/jcm.01262-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Adult invasive and non

More information

Streptococcus pyogenes

Streptococcus pyogenes Streptococcus pyogenes From Wikipedia, the free encyclopedia Streptococcus pyogenes S. pyogenes bacteria at 900x magnification. Scientific classification Kingdom: Eubacteria Phylum: Firmicutes Class: Cocci

More information

Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models

Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models Journal of Antimicrobial Chemotherapy (25) 56, 365 37 doi:.93/jac/dki24 Advance Access publication 7 July 25 Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection

More information

Macrolide-resistant phenotypes of invasive Streptococcus pneumoniae isolates in Serbia

Macrolide-resistant phenotypes of invasive Streptococcus pneumoniae isolates in Serbia Arch. Biol. Sci., Belgrade, 64 (4), 1377-1382, 2012 DOI:10.2298/ABS1204377G Macrolide-resistant phenotypes of invasive Streptococcus pneumoniae isolates in Serbia Ina GajiĆ, NataŠa Opavski, Vera MIJAČ

More information

Mupirocin Rationale for the EUCAST clinical breakpoints, version th July 2010

Mupirocin Rationale for the EUCAST clinical breakpoints, version th July 2010 Mupirocin Rationale for the EUCAST clinical breakpoints, version 1.0 6 th July 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European

More information

Prevalence of Complement-Mediated Cell Lysis-like Gene (sicg) in Streptococcus dysgalactiae subsp. equisimilis Isolates From Japan ( )

Prevalence of Complement-Mediated Cell Lysis-like Gene (sicg) in Streptococcus dysgalactiae subsp. equisimilis Isolates From Japan ( ) Original Article Clinical Microbiology Ann Lab Med 2017;37:297-304 https://doi.org/10.3343/alm.2017.37.4.297 ISSN 2234-3806 eissn 2234-3814 Prevalence of Complement-Mediated Cell Lysis-like Gene (sicg)

More information

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis Journal of Medical Microbiology (2004), 53, 879 885 DOI 10.1099/jmm.0.45655-0 Short Communication Correspondence Itzhak Brook ib6@georgetown.edu Received 1 March 2004 Accepted 18 May 2004 Discrepancies

More information

DiseaseINFOPACK: Streptococcus dysgalactiae (SDSE) (CAT: VADIP016) Background. ****New release September 2009***

DiseaseINFOPACK: Streptococcus dysgalactiae (SDSE) (CAT: VADIP016) Background. ****New release September 2009*** ****New release September 2009*** DiseaseINFOPACK: Streptococcus dysgalactiae (SDSE) (CAT: VADIP016) Proposal No/#PO : [Enter client specific #PO] Product Name : Comprehensive review/analysis of S. dysgalactiae

More information

878 Biomed Environ Sci, 2013; 26(11):

878 Biomed Environ Sci, 2013; 26(11): 878 Biomed Environ Sci, 01; 6(11): 877885 S INTRODUCTION treptococcus pyogenes (S. pyogenes, group A streptococcus, GAS ) is an important Grampositive pathogen that causes a wide spectrum of diseases varying

More information

Activity of Faropenem against Middle Ear Fluid Pathogens from Children with Acute Otitis Media in Costa Rica and Israel

Activity of Faropenem against Middle Ear Fluid Pathogens from Children with Acute Otitis Media in Costa Rica and Israel ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2007, p. 2230 2235 Vol. 51, No. 6 0066-4804/07/$08.00 0 doi:10.1128/aac.00049-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Activity

More information

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae AAC Accepted Manuscript Posted Online 26 January 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.04127-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 In vitro assessment

More information

MRSA Micro Scan Pos Combo 6J DADE BEHRING VCM

MRSA Micro Scan Pos Combo 6J DADE BEHRING VCM PKPD MRSA 1 1 2 1 1 2 17 1 26 17 3 16 vancomycinvcm methicillin-resistant Staphylococcus aureusmrsa 31 pharmacokineticpkparameter retrospective VCM 21 10 PK parameter Mann- Whitney U-test Cmax 37.1 µ gml29.942

More information

Characterization of Antimicrobial Resistance in Streptococcus pyogenes Isolates from the San Francisco Bay Area of Northern California

Characterization of Antimicrobial Resistance in Streptococcus pyogenes Isolates from the San Francisco Bay Area of Northern California JOURNAL OF CLINICAL MICROBIOLOGY, June 1999, p. 1727 1731 Vol. 37, No. 6 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Characterization of Antimicrobial

More information

ORIGINAL ARTICLE /j x

ORIGINAL ARTICLE /j x ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.00869.x Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy I. Serrano, M. Ramirez, the Portuguese Surveillance

More information

Guidelines for workup of Throat and Genital Cultures

Guidelines for workup of Throat and Genital Cultures Guidelines for workup of Throat and Genital Cultures 1 Acute Pharyngitis By far the most common infection of the upper respiratory tract Viral infection is by far the most common cause of pharyngitis The

More information

Pneumonia Community-Acquired Healthcare-Associated

Pneumonia Community-Acquired Healthcare-Associated Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious

More information

Guiding principles* for treating Mycoplasma pneumoniae pneumonia

Guiding principles* for treating Mycoplasma pneumoniae pneumonia 1 Guiding principles* for treating Mycoplasma pneumoniae pneumonia The Committee of Japanese Society of Mycoplasmology Shigeru Kohno (Chair, Nagasaki University) Tadashi Ishida (Kurashiki Central Hospital)

More information

MANAGEMENT of BACTERIAL RHINOSINUSITIS

MANAGEMENT of BACTERIAL RHINOSINUSITIS MANAGEMENT of BACTERIAL RHINOSINUSITIS Jennifer Le, PharmD Assistant Professor of Pharmacy Practice, College of Pharmacy, Western University of Health Sciences Martin S. Lipsky, MD Dean and Professor of

More information

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European

More information

Changing Epidemiology of Bacterial Meningitis in the United States

Changing Epidemiology of Bacterial Meningitis in the United States Changing Epidemiology of Bacterial Meningitis in the United States William R. Short, MD and Allan R. Tunkel, MD, PhD Address Department of Medicine, Medical College of Pennsylvania/Hahnemann University,

More information

Characterisation of group A streptococcal (GAS) isolates from children with tic disorders

Characterisation of group A streptococcal (GAS) isolates from children with tic disorders Indian J Med Res 119 (Suppl) May 2004, pp 174-178 Characterisation of group A streptococcal (GAS) isolates from children with tic disorders R. Creti, F. Cardona*, M. Pataracchia, C. von Hunolstein, G.

More information

Acute Bacterial Meningitis in Infants and Children Epidemiology and Management

Acute Bacterial Meningitis in Infants and Children Epidemiology and Management REVIEW ARTICLE Pediatr Drugs 2011; 13 (6): 385-400 1174-5878/11/0006-0385/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. Acute Bacterial Meningitis in Infants and Children Epidemiology

More information

Detection of the Efflux-Mediated Erythromycin Resistance Transposon in Streptococcus pneumoniae

Detection of the Efflux-Mediated Erythromycin Resistance Transposon in Streptococcus pneumoniae Original Article Clinical Microbiology Ann Lab Med 2015;35:57-61 http://dx.doi.org/10.3343/alm.2015.35.1.57 ISSN 2234-3806 eissn 2234-3814 Detection of the Efflux-Mediated Erythromycin Resistance Transposon

More information

Epidemiology of IGAS. Allison McGeer, MSc, MD, FRCPC Mount Sinai Hospital University of Toronto

Epidemiology of IGAS. Allison McGeer, MSc, MD, FRCPC Mount Sinai Hospital University of Toronto Epidemiology of IGAS Allison McGeer, MSc, MD, FRCPC Mount Sinai Hospital University of Toronto www.microbiology.mtsinai.on.ca Epidemiology of IGAS Median age: 48 years (range 0-101) 15% children (

More information

Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae

Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae International Journal of Antimicrobial Agents 31S (2008) S35 S39 Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae T. Matsumoto Department of Urology, School

More information

Incidence per 100,

Incidence per 100, Group B Streptococcus Surveillance Report 2005 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services Updated: January 2007 Background

More information

Antimicrobial susceptibility, carriage, children, day-care centres, orphanages, Streptococcus pneumoniae

Antimicrobial susceptibility, carriage, children, day-care centres, orphanages, Streptococcus pneumoniae ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01505.x Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre

More information

Received 15 November 2002/Returned for modification 19 January 2003/Accepted 19 March 2003

Received 15 November 2002/Returned for modification 19 January 2003/Accepted 19 March 2003 JOURNAL OF CLINICAL MICROBIOLOGY, June 2003, p. 2385 2390 Vol. 41, No. 6 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.6.2385 2390.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.

More information

UPPER RESPIRATORY TRACT INFECTIONS. IAP UG Teaching slides

UPPER RESPIRATORY TRACT INFECTIONS. IAP UG Teaching slides UPPER RESPIRATORY TRACT INFECTIONS 1 INTRODUCTION Most common problem in children below 5 years. In this age group they get about 6 8 episodes per year. It includes infections of nasal cavity, throat,

More information

State of Hong Kong Children

State of Hong Kong Children HK J Paediatr (new series) 2001;6:127-132 State of Hong Children Proceedings of The First Current Topic in Infectious Diseases: Consensus Meeting on Conjugate Vaccines of the Center of Infection, Faculty

More information

Acute Bacterial Sinusitis: The latest treatment recommendations. Objectives Having completed the learning activities, the participant will be able to:

Acute Bacterial Sinusitis: The latest treatment recommendations. Objectives Having completed the learning activities, the participant will be able to: Acute Bacterial Sinusitis: The latest treatment recommendations Presented by: Monica Tombasco, MS, MSNA, FNP-BC, CRNA Senior Lecturer Fitzgerald Health Education Associates, Inc., North Andover, MA Emergency

More information

Changes in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan

Changes in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan ORIGINAL ARTICLE Changes in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan Hisashi Shoji 1, Masayuki Maeda 2, Tetsuro Shirakura 3,

More information

Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection

Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection Journal of Antimicrobial Chemotherapy Advance Access published November 20, 2012 J Antimicrob Chemother doi:10.1093/jac/dks457 Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection

More information

Pediatric Respiratory Infections

Pediatric Respiratory Infections Pediatric Respiratory Infections Brenda Kelly PharmD BCPS Residency Program Director Virginia Mason Memorial, Yakima, Washington brendakelly@yvmh.org Disclosure The presenter has no actual or potential

More information

GROUP A STREPTOCOCCUS (GAS) INVASIVE

GROUP A STREPTOCOCCUS (GAS) INVASIVE GROUP A STREPTOCOCCUS (GAS) INVASIVE Case definition CONFIRMED CASE Laboratory confirmation of infection with or without clinical evidence of invasive disease: isolation of group A streptococcus (Streptococcus

More information

NEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS. 20th Symposium (spring 2003) Thursday May 22nd 2003

NEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS. 20th Symposium (spring 2003) Thursday May 22nd 2003 NEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS 20th Symposium (spring 2003) Thursday May 22nd 2003 The slides presented at this meeting are available on this site as "Web slide shows" and

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Rapenin (phenoxymethylpenicillin potassium) is indicated for the treatment of infections caused by penicillin-sensitive bacteria.

More information

Steven D. Brown* and Maria M. Traczewski. The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070

Steven D. Brown* and Maria M. Traczewski. The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2010, p. 2063 2069 Vol. 54, No. 5 0066-4804/10/$12.00 doi:10.1128/aac.01569-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Comparative

More information

Streptococcal Pharyngitis

Streptococcal Pharyngitis Streptococcal Pharyngitis Issues in Infectious Diseases Vol. 3 Series Editors Heinz Zeichhardt Brian W. J. Mahy Berlin Atlanta, GA Streptococcal Pharyngitis Optimal Management Volume Editors Jean Claude

More information

Phenoxymethyl penicillin versus co-amoxiclav in the treatment of acute streptococcal pharyngitis, and the role of /Mactamase activity in saliva

Phenoxymethyl penicillin versus co-amoxiclav in the treatment of acute streptococcal pharyngitis, and the role of /Mactamase activity in saliva Journal of Antimicrobial Chemotherapy (1996) 7, 1-18 Phexymethyl penicillin versus co-amoxiclav in the treatment of acute streptococcal pharyngitis, and the role of /Mactamase activity in saliva R. S.

More information

ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA

ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA Mafunise M 1, Le Roux MC 1, de Villiers BE 1, Ditsele RMM 1,2 1 Department of Microbiological

More information

Title: Comparison of illumigene Group A Streptococcus assay with culture of throat swabs from

Title: Comparison of illumigene Group A Streptococcus assay with culture of throat swabs from JCM Accepted Manuscript Posted Online 11 November 2015 J. Clin. Microbiol. doi:10.1128/jcm.02440-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 Title: Comparison of illumigene

More information

I have no disclosures

I have no disclosures Disclosures Streptococcal Pharyngitis: Update and Current Guidelines Richard A. Jacobs, MD, PhD Emeritus Professor of Medicine Division of Infectious Diseases I have no disclosures CID 2012:55;e 86-102

More information

Clindamycin strep throat dose

Clindamycin strep throat dose Clindamycin strep throat dose User Reviews for Clindamycin. Also known as: Cleocin, Cleocin HCl, Cleocin Pediatric, Cleocin Phosphate, Cleocin Phosphate ADD-Vantage. The following information is. 1 Answer

More information

Received 26 June 1995/Returned for modification 15 September 1995/Accepted 5 February 1996

Received 26 June 1995/Returned for modification 15 September 1995/Accepted 5 February 1996 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1996, p. 941 946 Vol. 40, No. 4 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Amoxicillin Dose-Effect Relationship with Streptococcus

More information

Pr Robert Cohen CHI Créteil France

Pr Robert Cohen CHI Créteil France EFFECT OF VACCINATION ON ANTIMICROBIAL RESISTANCE : THE EXAMPLE OF THE IMPACT OF PCVS ON ANTIBIOTIC RESISTANCE Pr Robert Cohen CHI Créteil France 1 DISCLOSURES I have received during the las 3 years honorarium

More information

ORIGINAL ARTICLE. Pneumococcal acute otitis media in children

ORIGINAL ARTICLE. Pneumococcal acute otitis media in children ORIGINAL ARTICLE Pneumococcal acute otitis media in children G. Kouppari 1, A. Zaphiropoulou 1, G. Stamos 1, V. Deliyianni 1, N. Apostolopoulos 2 and N. J. Legakis 3 1 Microbiology Laboratory, 2 ENT Department

More information

Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections

Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections Special Article https://doi.org/10.3947/ic.2017.49.4.326 Infect Chemother 2017;49(4):326-352 ISSN 2093-2340 (Print) ISSN 2092-6448 (Online) Infection & Chemotherapy Guidelines for the Antibiotic Use in

More information

TABLE OF CONTENTS 1.0 CLINICAL INFORMATION EPIDEMIOLOGY... 2

TABLE OF CONTENTS 1.0 CLINICAL INFORMATION EPIDEMIOLOGY... 2 September 2017 TABLE OF CONTENTS 1.0 CLINICAL INFORMATION... 1 2.0 EPIDEMIOLOGY... 2 3.0 CASE DEFINITIONS... 3 3.1 Case definitions for surveillance of invasive GAS disease... 3 3.2 Types of cases... 4

More information

Macrolides in Children

Macrolides in Children Second Meeting of the Subcommittee of the Expert Committee on the Selection and Use of Essential Medicines Geneva, 29 September to 3 October 2008 Macrolides in Children WHO Model List of Essential Medicines

More information

Streptococcus (gram positive coccus)

Streptococcus (gram positive coccus) #13 made by : aseel al-waked corrected by Shatha Khtoum date : 6/11/2016 Streptococcus (gram positive coccus) Slide 2 (56:00): Streptococci Facultative anaerobe Gram-positive usually chains (sometimes

More information

ARF & RHD Primordial and Primary Prevention

ARF & RHD Primordial and Primary Prevention ARF & RHD Primordial and Primary Prevention Bart Currie Infectious Diseases Department, Royal Darwin Hospital Global and Tropical Health Division, Menzies Northern Territory Medical Program, Flinders &

More information

Pharmacodynamic indices in targeting therapy of critical infections

Pharmacodynamic indices in targeting therapy of critical infections Pharmacodynamic indices in targeting therapy of critical infections P.M. Tulkens Cellular and Molecular Pharmacology, Catholic University of Louvain, Brussels, Belgium & International Society of Anti-infective

More information

Annual Epidemiological Report

Annual Epidemiological Report September 2018 Annual Epidemiological Report Key Facts Haemophilus 1 influenzae, in Ireland, 2017 In 2017, 45 cases of invasive Haemophilus influenzae disease were notified in Ireland (0.95 cases per 100,000

More information

Ampicillin Resistance Mechanisms in Clinical Haemophilus influenzae: What is Happening in Portugal?

Ampicillin Resistance Mechanisms in Clinical Haemophilus influenzae: What is Happening in Portugal? Ampicillin Resistance Mechanisms in Clinical Haemophilus influenzae: What is Happening in Portugal? M. Paula Bajanca-Lavado Haemophilus Reference Laboratory Infectious Disease Department National Institute

More information

Mycoplasma pneumoniae 23S rrna Gene Mutations and Mechanisms of Macrolide Resistance

Mycoplasma pneumoniae 23S rrna Gene Mutations and Mechanisms of Macrolide Resistance Mycoplasma pneumoniae 23S rrna Gene Mutations and Mechanisms of Macrolide Resistance Yun Ye, MS,* Suliang Li, MS, Yajun Li, PhD, Tianshun Ren, MS, and Kaige Liu, PhD ABSTRACT Objective: Resistant strains

More information

Beta-lactamase production should have no effect on Azithromycin activity.

Beta-lactamase production should have no effect on Azithromycin activity. AZIMEX Composition Azimex 250 Capsules Each capsule contains Azithromycin (as dihydrate) 250 mg Capsules & Powder Azimex 500 mg Capsules Each capsule contains Azithromycin (as dihydrate) 500 mg Azimex

More information

Treatment resistant STIs relevant to MSM

Treatment resistant STIs relevant to MSM Treatment resistant STIs relevant to MSM David A. Lewis FRCP (UK) PhD Centre for HIV and STIs National Institute for Communicable Diseases (NHLS) Johannesburg, South Africa Regional Director, IUSTI Africa

More information

Community Acquired Pneumonia

Community Acquired Pneumonia April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of

More information

Streptococcus(gram positive coccus) Dr. Hala Al Daghistani

Streptococcus(gram positive coccus) Dr. Hala Al Daghistani Streptococcus(gram positive coccus) Dr. Hala Al Daghistani Streptococci Facultative anaerobe Gram-positive usually chains (sometimes pairs) Catalase negative Non motile Hemolysins Lancefield Groups (C-carbohydrate

More information

Characteristics of Streptococcus pseudopneumoniae Isolated from Purulent Sputum Samples

Characteristics of Streptococcus pseudopneumoniae Isolated from Purulent Sputum Samples JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2006, p. 923 927 Vol. 44, No. 3 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.3.923 927.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Characteristics

More information